lipricain 25+25 mg/g creme
teva b.v. - lidocain, prilocain - creme - 25+25 mg/g
emla 25+25 mg/g creme
aspen pharma trading limited - lidocain, prilocain - creme - 25+25 mg/g
tapin 2,5 %+2,5 % creme
orifarm generics a/s - lidocain, prilocain - creme - 2,5 %+2,5 %
ovestin 1 mg/g vaginalcreme
aspen pharma trading ltd. - estriol - vaginalcreme - 1 mg/g
ovestin 1 mg/g vaginalcreme
orifarm a/s - estriol - vaginalcreme - 1 mg/g
ovestin 1 mg/g vaginalcreme
2care4 aps - estriol - vaginalcreme - 1 mg/g
axhidrox 2,2 mg/dosis creme
dr. august wolff gmbh & co. kg arzneimittel - glycopyrroniumbromid - creme - 2,2 mg/dosis
nulbia 25+25 mg/g creme
terix labs ltd. - lidocain, prilocain - creme - 25+25 mg/g
ovestin 1 mg/g vaginalcreme
paranova danmark a/s - estriol - vaginalcreme - 1 mg/g
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologiske - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.